This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
Paratek Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
09 Aug 23 | SellUS$107,727 | Evan Loh | Individual | 48,967 | US$2.20 |
Insider Trading Volume
Insider Buying: PRTK insiders have only sold shares in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 100 | 0.000174% |
Individual Insiders | 7,214,046 | 12.6% |
General Public | 22,422,358 | 39.1% |
Institutions | 27,685,854 | 48.3% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.5%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
3,693,981 | US$8.2m | 0% | 4.37% | |||
2,889,060 | US$6.4m | 0% | no data | |||
2,445,770 | US$5.5m | 0% | 1.38% | |||
2,228,066 | US$5.0m | 0% | no data | |||
1,934,276 | US$4.3m | 0% | 0.28% | |||
1,839,424 | US$4.1m | -3.92% | 0.32% | |||
1,734,037 | US$3.9m | 0% | 0.1% | |||
1,556,247 | US$3.5m | 0% | 1.05% | |||
1,327,857 | US$3.0m | 108% | 0.31% | |||
1,105,952 | US$2.5m | 102% | no data | |||
1,069,231 | US$2.4m | -6.99% | no data | |||
1,041,131 | US$2.3m | 0% | 1.17% | |||
894,894 | US$2.0m | -16.1% | no data | |||
764,274 | US$1.7m | 0% | 0.31% | |||
758,431 | US$1.7m | -17.2% | 0.1% | |||
623,284 | US$1.4m | 10.6% | no data | |||
491,724 | US$1.1m | 0% | 0.01% | |||
483,000 | US$1.1m | 0% | 3.61% | |||
479,504 | US$1.1m | 0% | 0.03% | |||
459,961 | US$1.0m | 0% | no data | |||
439,736 | US$980.6k | -5.8% | no data | |||
413,163 | US$921.4k | 2,380% | no data | |||
396,076 | US$883.2k | 12% | no data | |||
388,760 | US$866.9k | 678% | no data | |||
361,226 | US$805.5k | 0% | 0.51% |